Ozempic costs $349 per month for doses up to 1 mg and $499 per month for the 2 mg dose when paying out of pocket through the manufacturer’s pricing. With commercial insurance, copays can drop to as little as $25 per month. Without any discount or coverage, retail pharmacy prices can exceed $1,400 for a single pen, making the actual amount you pay heavily dependent on your insurance status and which savings programs you use.
Manufacturer Pricing by Dose
Novo Nordisk, the company that makes Ozempic, offers the drug directly at two price tiers for self-pay patients. The 0.25 mg, 0.5 mg, and 1 mg doses all cost $349 per month. The 2 mg dose costs $499 per month. These prices apply when you purchase through the manufacturer’s savings program rather than paying the full retail price at a pharmacy.
The retail price at pharmacies tells a different story. At major chains, the average cash price for a one-month Ozempic pen runs roughly $1,475 regardless of dose strength. The pens contain different concentrations but are priced nearly identically at the pharmacy counter. This is the sticker price before any coupons, insurance, or discount cards are applied, and almost nobody actually pays it.
What You Pay With Commercial Insurance
If you have private insurance through an employer or the marketplace, Ozempic is often covered for type 2 diabetes with a prior authorization. Insurers typically require your doctor to confirm that you have type 2 diabetes and meet at least one additional condition: that you haven’t responded well to first-line treatments like metformin, that your blood sugar levels remain elevated despite other medications, or that you have established heart disease. Some plans also want documentation that you’ve tried metformin before approving a GLP-1 medication.
Once approved, your copay depends on which formulary tier your plan places Ozempic on. Novo Nordisk offers a savings card for commercially insured patients that can bring the copay down to $25 per month, with a maximum savings of $100 per fill. That card is valid for up to 48 months, which covers four full years of treatment. Patients on government insurance programs like Medicare, Medicaid, or Tricare are not eligible for this savings card.
Medicare Coverage and the GLP-1 Bridge
Medicare’s relationship with Ozempic has two separate tracks. If you’re prescribed Ozempic for type 2 diabetes, standard Medicare Part D coverage applies. Your cost depends on your plan’s formulary, your deductible status, and which phase of coverage you’re in. Copays vary widely between Part D plans.
For weight management specifically, Medicare launched the GLP-1 Bridge program, which operates outside the normal Part D benefit structure. Eligible beneficiaries pay a flat $50 copay per fill regardless of where they are in their Part D coverage cycle. Low-income subsidies don’t reduce this copay further.
Qualifying for the Bridge program requires a prior authorization from your doctor confirming specific criteria. You must be at least 18 and meet one of three BMI-based thresholds: a BMI of 35 or higher on its own, a BMI of 30 or higher with certain conditions like heart failure, uncontrolled high blood pressure, or chronic kidney disease, or a BMI of 27 or higher with a history of prediabetes, heart attack, stroke, or symptomatic peripheral artery disease. The prescription must also be paired with ongoing lifestyle changes including structured nutrition and physical activity.
Savings for New and Uninsured Patients
Novo Nordisk runs an introductory offer for patients who are new to Ozempic savings programs. Between now and June 30, 2026, new self-pay patients can get their first two monthly fills of the 0.25 mg or 0.5 mg dose for $199 each. After those two introductory fills, the price shifts to the standard $349 or $499 per month depending on dose.
For uninsured patients using this program, the payments are processed outside of any insurance framework. That means they won’t count toward a deductible or any out-of-pocket maximum on a plan you might have. This is worth knowing if you’re considering whether to run Ozempic through insurance or pay out of pocket: the savings card route and the insurance route don’t combine.
Discount platforms like GoodRx advertise prices as low as $199 for certain Ozempic pens, representing a significant markdown from the $1,475 retail average. These prices fluctuate by pharmacy location and aren’t guaranteed, but they can be a useful backup if you don’t qualify for the manufacturer’s program.
Compounded Semaglutide as an Alternative
Compounded semaglutide, which contains the same active ingredient as Ozempic but is mixed by specialized compounding pharmacies, typically costs between $200 and $500 per month. The price varies based on your dose, the pharmacy, and whether you’re getting injectable or sublingual formulations. Custom titration schedules, where the pharmacy adjusts your dose gradually, tend to land in the $250 to $500 range.
Compounded versions are not FDA-approved products and don’t go through the same manufacturing process as brand-name Ozempic. The FDA has raised safety concerns about some compounded semaglutide products, and availability has shifted as regulatory scrutiny has increased. If cost is pushing you toward this option, it’s worth discussing the tradeoffs with your prescriber.
How U.S. Prices Compare Internationally
Ozempic’s U.S. pricing sits well above what patients pay in other countries. In Canada, the same GLP-1 medications cost roughly $300 to $500 per month at current prices, and pharmaceutical pricing experts at the University of Toronto have estimated that ongoing trade negotiations could push Canadian semaglutide prices below $100 for equivalent doses. European countries with national health systems negotiate even lower prices, though direct comparisons are complicated by differences in tax structures and distribution systems.
This gap is one reason some patients explore purchasing medications from Canadian or international pharmacies, though importing prescription drugs carries legal and safety considerations that vary by situation.
The Real Monthly Cost for Most People
Your actual cost lands somewhere on a wide spectrum. At one end, commercially insured patients with the manufacturer’s savings card pay $25 per month. Medicare beneficiaries who qualify for the GLP-1 Bridge pay $50. Self-pay patients using the introductory offer start at $199, then move to $349 or $499. And anyone paying full retail without any discounts faces roughly $1,475 per pen.
The most important step is checking whether your insurance covers Ozempic and what tier it falls on. If you’re uninsured or your plan doesn’t cover it, the manufacturer’s self-pay pricing at $349 to $499 is significantly lower than what pharmacies charge at the register. Stacking a discount card or the introductory offer on top of that can bring the first few months down further, giving you time to evaluate whether the medication is working before committing to the long-term cost.